The GLP Formula France (for Good Laboratory Practice ) is a set of quality principles governing the organization of non-clinical health safety studies. These principles guarantee the reliability, integrity and traceability of the data generated. In France, the implementation of the GLP is strictly regulated, particularly for trials conducted in the pharmaceutical, agrochemical, cosmetic and industrial chemical product sectors.
GLP was introduced in the 1970s by the OECD (Organisation for Economic Co-operation and Development) to address concerns about the validity of test data. The main objective is to ensure that studies are conducted to high standards, thus enabling regulatory authorities to assess risks to human health and the environment .
In France, the National Agency for Food, Environmental and Occupational Health Safety (ANSES) and the National Agency for the Safety of Medicines and Health Products (ANSM) are responsible for the inspection and monitoring of laboratories subject to the GLP.
The establishments concerned must meet strict criteria, including:
A documented quality system
Qualified and trained staff
Adapted facilities and equipment
Strict data management (traceability, archiving, etc.)
The implementation of an internal quality assurance program
https://www.facebook.com/GLP.Formula.France.Booster.Naturel/
https://www.facebook.com/events/979869770750915/
https://www.facebook.com/events/1381004353003543/
https://www.facebook.com/events/1240865424301545/
https://www.facebook.com/events/705851305400675/
https://www.facebook.com/share/p/15eTF9KzgC/
https://www.facebook.com/share/p/1AWCpQB3op/
https://www.facebook.com/share/p/1EEMcz1Lno/
https://www.facebook.com/share/p/1AopPK1Jfz/
https://www.facebook.com/groups/glp.formula.france.avance.stimule
https://www.facebook.com/groups/glp.formula.france.soutien.complet
https://www.facebook.com/groups/glp.formula.france.puissance.matrise
https://www.facebook.com/groups/glp.formula.france.mtabolique.globale
https://sites.google.com/view/glp-formula-france-performance/home
https://yodayo.com/posts/c9fa8b20-8448-41a9-9443-5793efb762cc
https://yodayo.com/posts/5ef2a439-328a-45d3-9984-9062830f28cf
https://yodayo.com/posts/07757bc1-3ad6-4e9b-9dd6-9285e3dc4261
https://yodayo.com/posts/edfb8055-94af-4fa3-aec1-1837a1f45438
https://yodayo.com/posts/c233ea54-4d47-4f2e-845e-467b315b6370
https://minecraftcommand.science/commands/83085
https://minecraftcommand.science/commands/83087
https://minecraftcommand.science/commands/83088
https://minecraftcommand.science/commands/83089
https://minecraftcommand.science/commands/83090
https://glp-nutrition-avance-stimule-la-satit-et-la-perte-de-poids.square.site/
https://glp-pro-soutien-mtabolique-intgral-base-de-plantes-et-de-fibre.square.site/
https://in.pinterest.com/pin/1142436630487650852
https://in.pinterest.com/pin/1142436630487650852
https://in.pinterest.com/pin/1142436630487650852
The GLP Formula France is mandatory for all non-clinical safety studies carried out for regulatory dossiers in sectors such as:
Medicines for human or veterinary use
Plant protection products (pesticides)
Food additives
Cosmetic products
Industrial chemicals (in accordance with REACH regulation)
The adoption of GLP allows:
Ensuring the validity of scientific results
Ensure the protection of consumers and the environment
Facilitate international acceptance of studies (particularly between OECD member countries)
GLP Formula France represents a fundamental pillar of regulated research in France. It embodies the laboratories' commitment to producing reliable, high-quality data, essential for health and environmental decision-making. Any organization conducting non-clinical studies for regulatory purposes must therefore comply with these requirements.